ArticleCell death & disease2025
Loss of KDM5A-mediated H3K4me3 demethylation promotes aberrant neural development by Wnt/β-catenin pathway activation.
Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Field-ridge structured bioactive Zn-based scaffold promotes bone regeneration via cellular mechanotransduction.Bioactive materials · 2027Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Neural tube defects (NTDs) are common and severe birth defects. Folate supplementation can prevent NTDs, but the underlying molecular mechanisms are unclear. Aberrant wnt/β-catenin pathway activation leads to defective anteroposterior patterning, resulting in NTDs, but little is known about whether epigenetic factors contribute to this process. Here, we performed ChIP and Cut&Tag to explore H3K4me3 in folate-deficient cells and NTDs mouse models. Our findings show folate deficiency increased H3K4me3 levels at wnt target genes promoters, enhancing their transcription. This effect was mediated by reduced expression of histone demethylase KDM5A, leading to the maintenance of H3K4me3 marks and activation of wnt/β-catenin signalling. Similarly, wnt/β-catenin pathway was activated in KDM5A-KO cells, differentiation of neuronal progenitors cells from mouse ESCs under folate deficiency and folate-deficient NTD mice. Intriguingly, KDM5A depletion in zebrafish embryos resulted in defective neurodevelopment and increased wnt signalling. Furthermore, the transcription factor PAX2 downregulated KDM5A under folate-deficient conditions. Clinically, increased H3K4me3 levels and wnt target genes expression were observed in low-folate NTDs brain samples. All these findings suggest KDM5A-dependent epigenetic regulation of wnt signaling is crucial in low folate NTDs, implicating a potential therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.